Women with multiple sclerosis (MS) often experience clinical improvement during pregnancy, indicating that sex hormones might have therapeutic effects in MS. Our previous studies have demonstrated that B cells and PD-L1 are crucial for E2 (17β-estradiol)-mediated protection against experimental autoimmune encephalomyelitis (EAE). We here demonstrate that the transfer of IL-10 + B cells into E2-treated PD-L1 −/− mice after EAE induction could partially restore E2-mediated protection and decrease the frequency of pro-inflammatory cells in the CNS compared to E2/saline treated PD-L1 −/− mice. Hence, co-administration of IL-10 + B cells and E2 might have a powerful therapeutic potential for treatment of EAE.
Introduction
Multiple sclerosis is a debilitating neurological and inflammatory autoimmune disease of central nervous system, which is characterized by demyelination and chronic neurodegeneration (Frohman et al., 2006; Lassmann et al., 2012) . Although the incidence of MS is higher in women, clinical improvement may occur during pregnancy, which is followed by temporary post-partum exacerbations (Confavreux et al., 1998; Vukusic et al., 2004) . It is now well accepted that sex hormones have immunoregulatory activity and may prevent exacerbations in MS during pregnancy. Our previous work demonstrated that treatment with pregnancy levels of estrogen (E2, 17β-estradiol) reduces CNS lesions in mice with experimental autoimmune encephalomyelitis (EAE) (Polanczyk et al., 2003; Offner and Polanczyk, 2006) . B cells were shown to have a dual role in EAE. Effector B cells contribute to the pathogenesis of EAE though the production of anti-myelin antibodies and as antigen presenting cells (APCs) (Owens et al., 2009; Molnarfi et al., 2013) . Conversely, regulatory B cells (Bregs) have been shown to have a protective role in EAE. Distinct subsets of IL-10 producing Bregs were identified as having immunosuppressing activity that inhibits the secretion of pro-inflammatory cytokines and migration of activated cells to the CNS (Bodhankar et al., 2013a (Bodhankar et al., , 2014 .
We previously demonstrated that 17β-estradiol (E2) could induce complete protection for EAE in WT C57BL/6 mice and increase the frequency of CD1d hi CD5 + Bregs (Bodhankar et al., 2011) . In addition, we demonstrated that this protection is mediated by the interaction of programmed death receptor 1 (PD-1) with PD-L1 but not PD-L2 on B cells (Bodhankar et al., 2013b 
